We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Mylan announced the commercial launch of its remdesivir under the brand name DESREM for COVID-19 treatment in India. It will manufacture DESREM in its injectable facility in Bangalore.